Consumers with cancer claims tied to Johnson & Johnson talc products are facing a shifting legal landscape after years of lawsuits, failed bankruptcy settlement efforts, and large jury verdicts. The cases generally center on allegations that talc-based baby powder products were linked to ovarian cancer or mesothelioma. If you have a cancer claim, it’s essential to ensure you have the right documentation.
Why Consumers Are Filing Talc Claims
Johnson & Johnson talc lawsuits generally involve people who say they used talc-based Johnson’s Baby Powder, Shower to Shower, or similar products for years before developing cancer. Many claims focus on ovarian cancer after use around that area of the body, while others involve mesothelioma, a cancer strongly associated with asbestos exposure.
Questions around talc and cancer depend partly on whether the talc contains asbestos. Talc with asbestos is generally accepted as capable of causing cancer if inhaled, while evidence around asbestos-free talc is less clear (source). That distinction is central to many lawsuits because plaintiffs often argue that talc products were contaminated with asbestos or carried risks that were not properly disclosed.
The Products Are No Longer Sold in Talc Form
Johnson & Johnson no longer sells talc-based Johnson’s Baby Powder. The company announced in 2022 that it would transition to an all cornstarch-based baby powder portfolio worldwide, with talc-based Johnson’s Baby Powder discontinued globally in 2023 (source).
That product change does not end older claims. Many lawsuits involve years of past talc use, often before the product was discontinued. For consumers, the key issue is usually not whether talc baby powder is still on store shelves. It is whether their past use, diagnosis, medical records, and state filing deadline support a possible claim.
Bankruptcy Settlement Efforts Have Failed
Johnson & Johnson has tried to resolve large numbers of talc claims through bankruptcy-related settlement plans, but those efforts have repeatedly faced court setbacks. In March 2025, a U.S. bankruptcy judge denied J&J’s proposed $9 billion Chapter 11 settlement plan to resolve talc baby powder claims (source). The judge found problems with the vote solicitation process and that J&J planned to return to the civil court system rather than appeal.
That matters for consumers because it means many claims may continue through civil litigation rather than being resolved through one approved bankruptcy settlement structure. It also means claimants should not assume there is a simple payout process already in place. The path may depend on whether a person’s claim is filed, where it is filed, what diagnosis is involved, and whether future settlement efforts emerge.
Recent Verdicts Show High Stakes and Uncertainty
Recent verdicts show that talc claims can produce major awards, but outcomes remain unpredictable. In October 2025, a Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma after alleged talc exposure (source). In another case, a Pennsylvania jury ordered J&J to pay $250,000 to the family of a woman who died from ovarian cancer after decades of talc baby powder use (source).
Those outcomes should be read carefully. A large verdict may be appealed, reduced, or handled differently after trial. A smaller verdict may still represent a finding of liability in a specific case. Johnson & Johnson has continued to dispute talc claims, so consumers should not treat any verdict as a guarantee of compensation.
What Evidence May Matter Most
A consumer with a cancer claim may need both medical and exposure evidence. Medical records can include pathology reports, oncology records, surgery notes, treatment summaries, imaging results, and death certificates in family claims. These records help establish the diagnosis and the timing of the illness.
Exposure evidence can be harder to gather, especially when product use happened years ago. Helpful information may include the product name, years of use, frequency of use, how the powder was applied, old containers, photos, receipts, family statements, or personal notes. A clear timeline can help connect product history, symptoms, diagnosis, treatment, and legal deadlines.
Ovarian Cancer and Mesothelioma Claims May Be Reviewed Differently
Ovarian cancer and mesothelioma claims may involve different evidence questions. Ovarian cancer claims often focus on long-term localized use of talc powder and whether the product carried adequate warnings. Mesothelioma claims often focus more directly on alleged asbestos contamination because asbestos exposure is a well-established cause of mesothelioma.
Consumers should also understand that not every cancer diagnosis will fit current talc litigation. A case review may examine age, family history, genetic risk, other exposures, medical history, and how long the person used the product. That does not automatically rule a claim in or out, but it can affect how lawyers and experts evaluate causation.
What Consumers Should Do Next
Consumers with cancer claims tied to J&J talc products should focus first on medical care and documentation. The most useful legal step is often gathering records before details are lost. That includes medical files, product-use history, pharmacy or store records when available, and notes from relatives who remember the product being used.
The lawsuits remain active, contested, and highly fact-specific. For consumers, the main takeaway is that a claim usually depends on diagnosis, exposure history, evidence, deadlines, and the current litigation path. Anyone considering a claim should ask a qualified attorney to review the full record rather than relying only on settlement headlines or online estimates.